Lokelma Powder, For Suspension
NDC Package 50090-6502-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lokelma (sodium zirconium cyclosilicate) powders is a medication used to treat high levels of potassium in the blood. This formulation utilizes a powder, for suspension delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-6502 and is authorized under FDA application NDA207078.

Identification & Billing

NDC Package Code
50090-6502-0
Package Description
30 PACKET in 1 BOX / 5 g in 1 PACKET
Product Code
50090-6502
11-Digit Billing Format
50090650200
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 2047633 - sodium zirconium cyclosilicate 5 GM Powder for Oral Suspension
  • RxCUI: 2047633 - sodium zirconium cyclosilicate 5000 MG Powder for Oral Suspension
  • RxCUI: 2047639 - LOKELMA 5 GM Powder for Oral Suspension
  • RxCUI: 2047639 - sodium zirconium cyclosilicate 5000 MG Powder for Oral Suspension [Lokelma]
  • RxCUI: 2047639 - Lokelma 5 GM Powder for Oral Suspension

Clinical Specifications

Proprietary Name
Lokelma
Non-Proprietary Name
Sodium Zirconium Cyclosilicate
Substance Name
Sodium Zirconium Cyclosilicate
Dosage Form
Powder, For Suspension - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle).
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SODIUM ZIRCONIUM CYCLOSILICATE 5 g/5g
Usage Information
This medication is used to treat high levels of potassium in the blood. It works by binding to potassium in the gut. This medication does not work right away, and should not be used to treat life-threatening high levels of potassium. High potassium levels can cause symptoms such as nausea, muscle weakness/tiredness, irregular heartbeats, or paralysis.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
Product Type
Human Prescription Drug
FDA Application #
NDA207078
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-04-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-6502-0 identifies a specific commercial package of 30 packet in 1 box / 5 g in 1 packet of Lokelma, a human prescription drug labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This powder, for suspension is formulated for oral use and contains sodium zirconium cyclosilicate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on September 04, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat high levels of potassium in the blood. It works by binding to potassium in the gut. This medication does not work right away, and should not be used to treat life-threatening high levels of potassium. High potassium levels can cause symptoms such as nausea, muscle weakness/tiredness, irregular heartbeats, or paralysis.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090650200. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-6502-0
11-Digit CMS (5-4-2)
50090-6502-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.